Home

Christopher James Frankenfield, CFO: Xilio Therapeutics XLO Sell · Filed 25/01/03

Trade details

Type
Insider sale
Amount
$6,814.92
Shares · price
6,954 sh · $0.98 a share
Held after
12,421 sh
Trade date
25/01/02
Filed
25/01/03
Days to filing
1 days

Sold 35.9% of holdings

Share of holding sold
35.9%

Xilio Therapeutics trades, last 26 weeks

What else happened in Xilio Therapeutics around then

Filed or reported within 30 days of the trade day · 24/12/03~25/02/01

Christopher James Frankenfield's recent trades

Christopher James Frankenfield, CFO — sold $6,815 of Xilio Therapeutics XLO · 35.9% of holdings · 10b5-1 plan | Whalegun